Pricing practices for prescription drugs are drawing intense scrutiny from inside and outside the healthcare industry.
In this page, I try to provide key background documents as well as up-to-date information on the trend.
Very often, I also mention pricing issues in a category of my blog posts as well as in tagged posts.
I update this page regularly, so stay tuned!
Recent articles
Express Scripts Drug Trend Report – Quarterly Update – always up-to-date
from-pipeline-to-profits-2016 – Kaiser Health News – 2016
How much should that drug cost? Depends what disease it treats – STAT News – 2016
Price of branded prescription drugs in the US doubles in 5 years – Financial Times – 2016 (subscription required)
Understanding Recent Trends in Generic Drug Pricing – US Dept Health & Human Services – 2016
Pricing and Market Access Outlook – IMS Health – 2015/2016
Pricing in the Market for Anti-Cancer Drugs – Journal of Economic Perspectives – 2015
Background articles & documents
Indication-specific pricing of pharmaceuticals in the United States healthcare system – Institute for Clinical and Economic Review – 2016
Analyzing Drug Pricing Mechanisms – Pharmaceutical Commerce – 2012
Difference in Cost of and Access to Pharmaceutical Products in the EU – European Parliament Study – 2011
